SCHEMBL5458325

SCHEMBL5458325

COc1ccccc1NC(=O)Nc1ccc(C2=CCN(C(=O)OC(C)(C)C)CC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 5/20 0.64
GRM5 P41594 2/20 0.55
GRM1 Q13255 2/20 0.55
RAB9A P51151 8/20 0.52
NPC1 O15118 7/20 0.52
MAPT P10636 6/20 0.52
SMN1; SMN2 Q16637 4/20 0.50
ALOX15 P16050 2/20 0.48
TP53 P04637 1/20 0.48
PDK4 Q16654 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
KDM4E B2RXH2 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5453589 0.89 NAMPT (0.57) NAMPTGRM5GRM1RAB9AMAPT
SCHEMBL5465684 0.87 NAMPT (0.65) NAMPTGRM5GRM1RAB9ANPC1
SCHEMBL5466920 0.87 RAB9A (0.56) NAMPTRAB9ANPC1MAPTSMN1; SMN2
SCHEMBL5473484 0.85 NAMPT (0.62) NAMPTGRM5GRM1PDK4ALDH1A1
SCHEMBL22325022 0.80 NAMPT (0.71) NAMPTGRM5GRM1RAB9ANPC1
SCHEMBL5460804 0.80 MAPT (0.68) NAMPTRAB9ANPC1MAPTSMN1; SMN2
SCHEMBL3317600 0.79 NAMPT (0.54) NAMPTGRM5GRM1PDK4
SCHEMBL5460878 0.79 NPC1 (0.62) NAMPTRAB9ANPC1MAPTSMN1; SMN2
SCHEMBL5458375 0.79 NAMPT (0.58) NAMPTGRM5GRM1RAB9ANPC1
SCHEMBL5456870 0.78 NAMPT (0.64) NAMPTRAB9ANPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NAMPT 324/4885GRM5 2380/4885GRM1 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.